Emergent Biosolutions (EBS)

$5.95 +0.32 (5.68%)
Market Cap 305.59M
Revenue (ttm) 1.04B
Net Income (ttm) -190.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 8.65
Profit Margin -18.26%
Debt to Equity Ratio 1.20
Volume 746,780
Avg Vol 1,203,596
Day's Range N/A - N/A
Shares Out 54.28M
Stochastic %K 0%
Beta 1.97
Analysts Sell
Price Target $13.50

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax va...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 631 3200
Address:
300 Professional Drive, Gaithersburg, United States
zredpill
zredpill Aug. 5 at 12:32 AM
$EBS why up AH?
0 · Reply
zredpill
zredpill Aug. 4 at 11:11 PM
$EBS what’s the volume AH?
1 · Reply
Kupper
Kupper Aug. 4 at 9:19 PM
$EBS good to see some confidence going into earnings.
0 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 8:32 PM
$EBS the punchline
0 · Reply
zredpill
zredpill Aug. 4 at 8:26 PM
$EBS “global strategic marketing” How I take it is they’ll be selling products worldwide … bEEEEeerisH…
2 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 8:21 PM
$EBS You ain't seen nothing yet hedgies. (PS: the answer is 'day traders' not 'retailos')
1 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 7:16 PM
$EBS FFS!
1 · Reply
billywilliamz
billywilliamz Aug. 4 at 7:09 PM
$EBS only 11% more to go up to break back even with last week !
1 · Reply
KnuckleSandwich
KnuckleSandwich Aug. 4 at 7:07 PM
$EBS here comes the money
0 · Reply
KnuckleSandwich
KnuckleSandwich Aug. 4 at 6:49 PM
$EBS Today... our little company had a very big day.
0 · Reply
Latest News on EBS
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

Jul 28, 2025, 8:50 AM EDT - 7 days ago

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Jul 28, 2025, 8:50 AM EDT - 7 days ago

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 15, 2025, 7:30 AM EDT - 20 days ago

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Jul 8, 2025, 4:45 PM EDT - 27 days ago

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Jul 2, 2025, 4:05 PM EDT - 4 weeks ago

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Jun 23, 2025, 8:05 AM EDT - 6 weeks ago

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Jun 20, 2025, 2:25 PM EDT - 6 weeks ago

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Emergent BioSolutions Announces Addition to Russell 3000® Index

Jun 20, 2025, 8:13 AM EDT - 6 weeks ago

Emergent BioSolutions Announces Addition to Russell 3000® Index

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Jun 5, 2025, 7:00 AM EDT - 2 months ago

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Emergent BioSolutions to Participate in Upcoming Investor Conferences

May 14, 2025, 7:32 AM EDT - 2 months ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

May 7, 2025, 10:01 PM EDT - 3 months ago

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

Emergent BioSolutions Reports First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 3 months ago

Emergent BioSolutions Reports First Quarter 2025 Financial Results

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

May 1, 2025, 5:07 PM EDT - 3 months ago

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 22, 2025, 8:00 AM EDT - 3 months ago

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Emergent BioSolutions Announces Stock Repurchase Program

Mar 31, 2025, 8:00 AM EDT - 4 months ago

Emergent BioSolutions Announces Stock Repurchase Program

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Mar 20, 2025, 4:30 PM EDT - 4 months ago

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Mar 20, 2025, 8:06 AM EDT - 4 months ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 19, 2025, 4:30 PM EDT - 4 months ago

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Mar 18, 2025, 8:00 AM EDT - 4 months ago

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Mar 13, 2025, 8:29 AM EDT - 5 months ago

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Mar 12, 2025, 8:00 AM EDT - 5 months ago

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 10, 2025, 9:14 AM EDT - 5 months ago

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:58 PM EST - 5 months ago

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 4:23 PM EST - 5 months ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 18, 2025, 8:55 AM EST - 5 months ago

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Feb 7, 2025, 8:06 AM EST - 6 months ago

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Jan 16, 2025, 8:00 AM EST - 7 months ago

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Jan 14, 2025, 7:53 AM EST - 7 months ago

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Jan 14, 2025, 7:30 AM EST - 7 months ago

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Jan 13, 2025, 9:27 AM EST - 7 months ago

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Jan 8, 2025, 7:45 AM EST - 7 months ago

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

Jan 8, 2025, 7:30 AM EST - 7 months ago

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

Dec 2, 2024, 5:49 PM EST - 8 months ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

SIGA

Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic

Nov 8, 2024, 9:25 AM EST - 9 months ago

Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

Nov 7, 2024, 2:06 PM EST - 9 months ago

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:08 PM EST - 9 months ago

Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

Nov 6, 2024, 4:49 PM EST - 9 months ago

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development

Nov 4, 2024, 7:30 AM EST - 9 months ago

Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

Oct 23, 2024, 7:30 AM EDT - 10 months ago

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

Oct 8, 2024, 5:32 PM EDT - 10 months ago

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario

Oct 4, 2024, 9:48 AM EDT - 10 months ago

Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

Sep 26, 2024, 8:05 AM EDT - 11 months ago

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines

Sep 25, 2024, 10:33 AM EDT - 11 months ago

Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

Sep 25, 2024, 7:07 AM EDT - 11 months ago

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

Sep 12, 2024, 8:30 AM EDT - 11 months ago

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

Sep 3, 2024, 7:08 AM EDT - 11 months ago

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho's Jared Holz

Aug 30, 2024, 6:45 PM EDT - 1 year ago

Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho's Jared Holz

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

Aug 30, 2024, 8:16 AM EDT - 1 year ago

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection

Aug 30, 2024, 7:43 AM EDT - 1 year ago

Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection

Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine

Aug 30, 2024, 7:15 AM EDT - 1 year ago

Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine

zredpill
zredpill Aug. 5 at 12:32 AM
$EBS why up AH?
0 · Reply
zredpill
zredpill Aug. 4 at 11:11 PM
$EBS what’s the volume AH?
1 · Reply
Kupper
Kupper Aug. 4 at 9:19 PM
$EBS good to see some confidence going into earnings.
0 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 8:32 PM
$EBS the punchline
0 · Reply
zredpill
zredpill Aug. 4 at 8:26 PM
$EBS “global strategic marketing” How I take it is they’ll be selling products worldwide … bEEEEeerisH…
2 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 8:21 PM
$EBS You ain't seen nothing yet hedgies. (PS: the answer is 'day traders' not 'retailos')
1 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 7:16 PM
$EBS FFS!
1 · Reply
billywilliamz
billywilliamz Aug. 4 at 7:09 PM
$EBS only 11% more to go up to break back even with last week !
1 · Reply
KnuckleSandwich
KnuckleSandwich Aug. 4 at 7:07 PM
$EBS here comes the money
0 · Reply
KnuckleSandwich
KnuckleSandwich Aug. 4 at 6:49 PM
$EBS Today... our little company had a very big day.
0 · Reply
Daniel3303
Daniel3303 Aug. 4 at 6:45 PM
$EBS Adding a few
1 · Reply
BavarianStallion
BavarianStallion Aug. 4 at 6:41 PM
$EBS waiting for earnings is like waiting for christmas as you were a child
3 · Reply
billywilliamz
billywilliamz Aug. 4 at 6:31 PM
$EBS y up ?
1 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 6:22 PM
$EBS So, um what happened to them 'WEAK'-ly doptions? They disappeared on the 1 year anniversary they appeared.
0 · Reply
KnuckleSandwich
KnuckleSandwich Aug. 4 at 6:20 PM
$EBS execs at EBS are getting excited????...I would read between the lines.. https://www.linkedin.com/posts/emergent-biosolutions_kathleen-love-weitz-vice-president-global-activity-7358165288955101184-9yx8?utm_source=share&utm_medium=member_desktop&rcm=ACoAAABo8SUBMLqpZ_H06RmCNSuDlWI1eH2J9nI
0 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 6:11 PM
$EBS This thing has 2 floors and 1 high ceiling.
4 · Reply
Hi_there
Hi_there Aug. 4 at 5:58 PM
$EBS I like the situation already!!!
0 · Reply
billywilliamz
billywilliamz Aug. 4 at 5:08 PM
$EBS DCB
0 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 5:07 PM
$EBS real!!
0 · Reply
DimebagDarrell_
DimebagDarrell_ Aug. 4 at 5:07 PM
$EBS Averaged up today!
0 · Reply
ComradeKomisar
ComradeKomisar Aug. 4 at 4:37 PM
$EBS 😭
0 · Reply
biotechworld
biotechworld Aug. 4 at 3:36 PM
$EBS started 50% position today. Will continue accumulating into earnings.
2 · Reply